Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...
News Medical on MSN8d
Pheno Therapeutics granted clinical trial authorization for lead multiple sclerosis therapeutic candidate PTD802Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has received clinical trial ...
News Medical on MSN8d
Pheno Therapeutics receives clinical trial authorization for novel multiple sclerosis therapeuticPheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...
Pheno Therapeutics Limited has received clinical trial authorisation (CTA) from the UK’s MHRA for its lead candidate, PTD802.
Demyelination in MS occurs when the immune system attacks and damages the myelin sheaths that insulate and nourish axons and nerve fibres in the central nervous system, leading to multifocal ...
Pheno Therapeutics has gained clinical trial authorisation (CTA) from the UK's MHRA for its small molecule therapeutic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback